Article

Zeiss questions patent infringement with Signet

San Diego?Carl Zeiss Vision International GmbH and Carl Zeiss Vision Inc. (CZV) have filed a patent infringement lawsuit against Signet Armorlite Inc., San Marcos, CA, in the U.S. District Court for the Southern District of California.

San Diego-Carl Zeiss Vision International GmbH and Carl Zeiss Vision Inc. (CZV) have filed a patent infringement lawsuit against Signet Armorlite Inc., San Marcos, CA, in the U.S. District Court for the Southern District of California.

CZV asserts that Signet's line of Kodak Unique spectacle lenses and the process used to make those lenses infringes United States Patent No. 6,089,713 ('713). No comment was available from Signet.

Fred Howard, CZV president and general manager-Americas, said, "Our freeform lens technology covered by the '713 patent is an essential part of our approach to progressive lens customization. CZV is one of the world's leading creators of intellectual property in the field of ophthalmic lenses, and we intend to protect that property against unauthorized exploitation."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.